TUBectomy med forsinket oophorectomy hos højrisikokvinder for at vurdere sikkerheden ved forebyggelse (TUBA-WISP-II)
TUBectomy med forsinket Oophorectomy som alternativ til risikoreducerende Salpingo-ooforektomi hos højrisikokvinder for at vurdere sikkerheden ved forebyggelse: TUBA-WISP II-undersøgelse.
The aim of the project is to evaluate the risk-reducing salpingectomy with delayed oophorectomy as an alternative for risk-reducing salpingo-oophorectomy in high risk women with respect to ovarian cancer incidence.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
In BRCA1/2 gene mutation carriers, a risk-reducing salpingo-oophorectomy (RRSO) is recommended around the age of 40. This recommendation is based on a 10-40% life-time risk of ovarian cancer in this population and disappointing results of ovarian cancer surveillance for early detection. Moreover, the mortality rate of ovarian cancer is high. Effects of RRSO are a decrease in ovarian cancer risk (80-96%) on one hand and immediate onset of menopause and non-cancer related morbidity on the other hand. The fifty percent breast cancer risk reduction after RRSO has become disputable in the last years. Based on multiple studies showing that most high-grade serous ovarian cancers develop at the distal end of the Fallopian tube, an innovative strategy for RRSO has been developed for this study proposal: risk-reducing salpingectomy (RRS) with delayed risk-reducing oophorectomy (RRO). However, the safety of this strategy has not been proven yet. Before implementing this innovative strategy as standard care we need to investigate the long term effects on ovarian cancer incidence.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Joanne A. de Hullu, MD, PhD
- Telefonnummer: +31 (0) 24 36 16683
- E-mail: Joanne.deHullu@radboudumc.nl
Undersøgelse Kontakt Backup
- Navn: Karen H. Lu, MD, PhD
- Telefonnummer: (713) 745-8902
- E-mail: khlu@mdanderson.org
Studiesteder
-
-
-
Brisbane, Australien
- Rekruttering
- The Mater Hospital
-
Kontakt:
- Ngaire Latch
- Telefonnummer: +61394266666
- E-mail: ngaire.latch@unimelb.edu.au
-
Melbourne, Australien
- Rekruttering
- Monash Health
-
Kontakt:
- Martha Hickey
-
Melbourne, Australien
- Rekruttering
- Peter MacCallum Centre
-
Kontakt:
- Martha Hickey
-
Melbourne, Australien
- Rekruttering
- Royal Womens Hospital
-
Kontakt:
- Martha Hickey
-
-
New South Wales
-
Sydney, New South Wales, Australien, 2050
- Rekruttering
- Chris O'Brien Lifehouse
-
Kontakt:
- Ngaire Latch
- Telefonnummer: +61285140000
- E-mail: ngaire.latch@unimelb.edu.au
-
Sydney, New South Wales, Australien, 2145
- Rekruttering
- Westmead hospital
-
Kontakt:
- Ngaire Latch
- Telefonnummer: +61288905555
- E-mail: ngaire.latch@unimelb.edu.au
-
-
Queensland
-
Brisbane, Queensland, Australien, 4001
- Rekruttering
- St Andrew War Memorial Hospital
-
Kontakt:
- Ngaire Latch
- Telefonnummer: +61738344444
- E-mail: ngaire.latch@unimelb.edu.au
-
Brisbane, Queensland, Australien, 4006
- Rekruttering
- Royal Brisbane Hospital
-
Kontakt:
- Ngaire Latch
- Telefonnummer: +61736468111
- E-mail: ngaire.latch@unimelb.edu.au
-
Brisbane, Queensland, Australien, 4120
- Rekruttering
- Greenslopes Private Hospital
-
Kontakt:
- Ngaire Latch
- Telefonnummer: +61733947111
- E-mail: ngaire.latch@unimelb.edu.au
-
-
South Australia
-
Adelaide, South Australia, Australien, 5000
- Rekruttering
- Royal Adelaide Hospital
-
Kontakt:
- Ngaire Latch
- Telefonnummer: +61870740000
- E-mail: ngaire.latch@unimelb.edu.au
-
-
Victoria
-
Melbourne, Victoria, Australien, 3050
- Rekruttering
- Frances Perry House
-
Kontakt:
- Ngaire Latch
- Telefonnummer: +61393445000
- E-mail: ngaire.latch@unimelb.edu.au
-
Melbourne, Victoria, Australien, 3084
- Rekruttering
- Mercy Hospital
-
Kontakt:
- Ngaire Latch
- Telefonnummer: +61 3 8458 4444
- E-mail: ngaire.latch@unimelb.edu.au
-
Richmond, Victoria, Australien, 3121
- Rekruttering
- Epworth Hospital
-
Kontakt:
- Ngaire Latch
- Telefonnummer: +61394266666
- E-mail: ngaire.latch@unimelb.edu.au
-
St Albans, Victoria, Australien, 3021
- Rekruttering
- Western Health
-
Kontakt:
- Ngaire Latch
- Telefonnummer: 03 8345 1333
- E-mail: ngaire.latch@unimelb.edu.au
-
-
Western Australia
-
Perth, Western Australia, Australien, 6008
- Rekruttering
- King Edward Memorial Hospital
-
Kontakt:
- Ngaire Latch
- Telefonnummer: +61864582222
- E-mail: ngaire.latch@unimelb.edu.au
-
-
-
-
-
Brussels, Belgien
- Rekruttering
- Hopital Universitaire Bruxelles
-
Kontakt:
- Maxime Fastrez
-
Leuven, Belgien
- Rekruttering
- Universitair Ziekenhuis Leuven
-
Kontakt:
- Susanne Housmans
-
-
-
-
-
São Paulo, Brasilien
- Rekruttering
- AC Camargo Cancer Centre
-
Kontakt:
- Glauco Baiocchi
-
-
-
-
-
Vancouver, Canada
- Rekruttering
- Vancouver General Hospital
-
Kontakt:
- Janice Kwon
-
-
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60637
- Rekruttering
- UChicago Medicine
-
Kontakt:
- Kathryn Mills
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02215
- Rekruttering
- Dana Farber Cancer Institute
-
Kontakt:
- Karen Lu
-
-
Minnesota
-
Rochester, Minnesota, Forenede Stater, 55905
- Rekruttering
- Mayo Clinic
-
Kontakt:
- Karen Lu
-
-
Missouri
-
St Louis, Missouri, Forenede Stater, 63110
- Rekruttering
- Washington University Medical Center
-
Kontakt:
- Andrea Hagemann
-
-
New York
-
New York, New York, Forenede Stater, 10065
- Rekruttering
- Memorial Sloan Kettering Cancer Center
-
Kontakt:
- Kara Long Roche
-
New York, New York, Forenede Stater, 10029
- Rekruttering
- Mount Sinai Hospital
-
Kontakt:
- Stephanie Blank
-
-
North Carolina
-
Durham, North Carolina, Forenede Stater, 27705
- Rekruttering
- Duke University Hospital
-
Kontakt:
- Haley Moss
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- Rekruttering
- Hospital of the University of Pennsylvania
-
Kontakt:
- Sarah Kim
-
-
Texas
-
Houston, Texas, Forenede Stater, 77030-4009
- Rekruttering
- MD Anderson Cancer Centre
-
Kontakt:
- Karen Lu
-
Houston, Texas, Forenede Stater, 77026
- Rekruttering
- Harris Health Lyndon B. Johnson Hospital
-
Kontakt:
- Michaela Onstad-Grinsfelder
-
-
Washington
-
Seattle, Washington, Forenede Stater, 98195
- Rekruttering
- University of Washington
-
Kontakt:
- Elizabeth Swisher
-
-
-
-
-
Amsterdam, Holland
- Rekruttering
- Antoni van Leeuwenhoek
-
Kontakt:
- Teska Schuurman, MD, PhD
-
Amsterdam, Holland
- Rekruttering
- Amsterdam University Medical Center
-
Kontakt:
- Luc van Lonkhuijzen, MD, PhD
-
Breda, Holland
- Rekruttering
- Amphia
-
Kontakt:
- Janneke Hoogstad, MD, PhD
-
Enschede, Holland
- Rekruttering
- Medisch Spectrum Twente
-
Kontakt:
- Nathalie Reesink-Peters, MD, PhD
-
Groningen, Holland
- Rekruttering
- University Medical Center Groningen
-
Kontakt:
- Marise Wagener, MD, PhD
-
Leeuwarden, Holland
- Rekruttering
- Medical Center Leeuwarden
-
Kontakt:
- Mirjam Apperloo, MD, PhD
-
Leiden, Holland
- Rekruttering
- Leiden University Medical Center
-
Kontakt:
- Katja Gaarenstroom, MD, PhD
-
Rotterdam, Holland
- Rekruttering
- Erasmus Medical Center
-
Kontakt:
- Eva Roes, MD, PhD
-
Utrecht, Holland
- Rekruttering
- University Medical Center Utrecht
-
Kontakt:
- Ronald Zweemer, Prof, MD, PhD
-
Veldhoven, Holland
- Rekruttering
- Maxima Medical Center
-
Kontakt:
- Sjors Coppus, MD, PhD
-
Zwolle, Holland
- Rekruttering
- Isala Klinieken
-
Kontakt:
- Arnold-Jan Kruse, MD, PhD
-
-
Gelderland
-
Nijmegen, Gelderland, Holland
- Rekruttering
- Radboudumc
-
Kontakt:
- Joanne A. de Hullu, MD, PhD
- Telefonnummer: +31 (0) 24 36 16683
- E-mail: Joanne.deHullu@radboudumc.nl
-
-
Limburg
-
Maastricht, Limburg, Holland
- Rekruttering
- Maastricht University Medical Center
-
Kontakt:
- Brigitte Slangen, MD, PhD
-
-
North Brabant
-
Eindhoven, North Brabant, Holland, 5623 EJ
- Rekruttering
- Catharina Ziekenhuis
-
Kontakt:
- Jurgen M.J. Piek, MD, PhD
- E-mail: jurgen.piek@catharinaziekenhuis.nl
-
Tilburg, North Brabant, Holland
- Rekruttering
- Elisabeth-TweeSteden Ziekenhuis
-
Kontakt:
- Caroline Vos, MD
-
-
-
-
-
Cork, Irland
- Rekruttering
- Cork University Hospital
-
Kontakt:
- Zibi Marchoki
-
-
-
-
-
Bologna, Italien
- Rekruttering
- Universita di Bologna
-
Kontakt:
- Myriam Perrone
-
Milan, Italien
- Rekruttering
- Humanitas San Pio X
-
Kontakt:
- Fabio Martinelli
-
Monza, Italien
- Rekruttering
- San Gerardo Hospital
-
Kontakt:
- Robert Fruscio
-
Rome, Italien
- Rekruttering
- Gemelli Hospital
-
Kontakt:
- Claudia Marchetti
-
-
-
-
-
Mexico City, Mexico
- Rekruttering
- Instituto Nacional de Cancerología
-
Kontakt:
- David Cantu
-
-
-
-
-
Nordbyhagen, Norge
- Aktiv, ikke rekrutterende
- Akershus University Hospital
-
Oslo, Norge
- Rekruttering
- Oslo University Hospital
-
Kontakt:
- Anne Dorum
-
Stavanger, Norge
- Rekruttering
- Stavanger Uniersity Hospital
-
Kontakt:
- Anne Dorum
-
-
-
-
-
Gdynia, Polen
- Rekruttering
- Gdynia Oncology Centre
-
Kontakt:
- Maciej Stukan
-
Katowice, Polen
- Rekruttering
- Medical University of Silesia
-
Kontakt:
- Krzysztof Nowosielski
-
Katowice, Polen
- Rekruttering
- Bonifraterskie Centrum Medyczne
-
Kontakt:
- Monika Bodjys-Szyndlar
-
Warsaw, Polen
- Rekruttering
- National Cancer Institute Warsaw
-
Kontakt:
- Agnieszka Rychlik
-
-
-
-
-
Barcelona, Spanien
- Rekruttering
- Vall D'Hebron Barcelona
-
Kontakt:
- Judith Balmana
-
-
-
-
-
Stockholm, Sverige
- Rekruttering
- Karolinksa Institutet
-
Kontakt:
- Angelique Flöter-Radestad
-
-
-
-
-
Amberg, Tyskland
- Rekruttering
- Klinikum St. Marien Amberg
-
Kontakt:
- Thomas Papathemelis
-
Bad Homburg, Tyskland
- Rekruttering
- Hochtaunus-Kliniken Bad Homburg
-
Kontakt:
- Dominik Denschlag
-
Berlin-Spandau, Tyskland
- Rekruttering
- Evangelische Waldkrankenhaus Spandau Berlin
-
Kontakt:
- Katharina Carrizo
-
Detmold, Tyskland
- Rekruttering
- Klinikum Lippe Detmold
-
Kontakt:
- Beyhan Ataseven
-
Dresden, Tyskland
- Rekruttering
- Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden
-
Kontakt:
- Pauline Wimberger
-
Düsseldorf, Tyskland
- Rekruttering
- Universitätsklinikum Düsseldorf
-
Kontakt:
- Tanja Fehm
-
Düsseldorf, Tyskland
- Rekruttering
- Florence-Nightingale-Krankenhaus Düsseldorf
-
Kontakt:
- Saher Baransi
-
Essen, Tyskland
- Rekruttering
- Evang. Kliniken Essen-Mitte
-
Kontakt:
- Philipp Harter
-
Hamburg, Tyskland
- Rekruttering
- Universitätsklinikum Hamburg-Eppendorf
-
Kontakt:
- Barbara Schmalfeld
-
Hamburg, Tyskland
- Rekruttering
- Mammazentrum Hamburg am Krankenhaus Jerusalem
-
Kontakt:
- Felix Hilpert
-
Hanover, Tyskland
- Rekruttering
- Medizinische Hochschule Hannover
-
Kontakt:
- Elna Kühnle
-
Heidelberg, Tyskland
- Rekruttering
- Medizinische Fakultät Mannheim der Universität Heidelberg
-
Kontakt:
- Frederik Marmé
-
Heidelberg, Tyskland
- Rekruttering
- Universitäts-Frauenklinik Heidelberg
-
Kontakt:
- Oliver Zivanovic
-
Mainz, Tyskland
- Rekruttering
- Universitätsmedizin Mainz
-
Kontakt:
- Anette Hasenburg
-
München, Tyskland
- Rekruttering
- Rotkreuzklinikum München
-
Kontakt:
- Martin Pölcher
-
München, Tyskland
- Rekruttering
- Klinikum rechts an der Isar Technische Universität München
-
Kontakt:
- Holger Bronger
-
Münster, Tyskland
- Rekruttering
- Universitätsklinikum Münster
-
Kontakt:
- Carl Christian Opitz
-
-
-
-
-
Montevideo, Uruguay
- Rekruttering
- Hospital Británico
-
Kontakt:
- Santiago Scasso
-
-
-
-
-
Graz, Østrig
- Rekruttering
- Medical University of Graz
-
Kontakt:
- Karl Tamussino
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
-
Women with a class 5 (definitely pathogenic) BRCA1, BRCA2, RAD51C, RAD51D, BRIP1 or PALB2 germline mutation in one of the participating centers.
-
Age at inclusion;
- BRCA1: 25-40 years
- BRCA2: 25-45 years
- RAD51C, RAD51D, BRIP1 & PALB2: 25-50 years
-
Childbearing completed
-
Presence of at least one fallopian tube
-
Participants may have a personal history of non-ovarian malignancy
-
Informed consent must be obtained and documented according to national and local regulatory requirements and the local rules followed in the institution.
Exclusion Criteria:
- Postmenopausal status (natural menopause or due to treatment)
- Wish for second stage RRO within two years after RRS
- Legally incapable
- Prior bilateral salpingectomy
- A personal history of ovarian, fallopian tube or peritoneal cancer
- Current diagnosis or treatment for malignant disease
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Risk-reducing salpingectomy with delayed oophorectomy
Risk-reducing salpingectomy after the completion of childbearing with delayed oophorectomy. |
|
|
Aktiv komparator: Risk-reducing salpingo-oophorectomy
Risk-reducing salpingo-oophorectomy. |
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
High grade serous (ovarian) cancer incidence
Tidsramme: Until the age of 45 for BRCA1 and 50 for BRCA2 germline mutation carriers
|
High grade serous (ovarian) cancer incidence |
Until the age of 45 for BRCA1 and 50 for BRCA2 germline mutation carriers
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of (pre)malignant findings in tubes/ovaries
Tidsramme: 6 weeks after each surgery
|
Incidence of (pre)malignant findings in tubes/ovaries at risk-reducing salpingectomy, oophorectomy and salpingo-oophorectomy. |
6 weeks after each surgery
|
|
Peri-operative morbidity and mortality
Tidsramme: 6 weeks after each surgery
|
Peri-operative morbidity and mortality |
6 weeks after each surgery
|
|
Incidence of pelvic cancer (other than ovarian cancer)
Tidsramme: Up to the age of 70
|
Incidence of pelvic cancer (other than ovarian cancer) |
Up to the age of 70
|
|
Incidence of breast cancer
Tidsramme: Up to the age of 70
|
Incidence of breast cancer |
Up to the age of 70
|
|
Uptake of risk reducing oophorectomy
Tidsramme: Up to the age of 70
|
Uptake of risk reducing oophorectomy after risk reducing salpingectomy |
Up to the age of 70
|
Andre resultatmål
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
High grade serous (ovarian) cancer incidence at the age of 70
Tidsramme: Up to the age of 70
|
Exploratory outcome measure |
Up to the age of 70
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Ledende efterforsker: Joanne A. de Hullu, MD, PhD, Radboud University Medical Center
- Ledende efterforsker: Rosella P.M.G. Hermens, MD,PhD, Radboud University Medical Center
- Ledende efterforsker: Elizabeth M. Swisher, MD, PhD, University of Washington
- Ledende efterforsker: Karen H. Lu, MD, PhD, Moffitt Cancer Center & Research Institute
Publikationer og nyttige links
Generelle publikationer
- Pennington KP, Pugh SL, Huh W, Walker JL, Jewell E, Havrilesky LJ, Carter J, Muller CY, Drapkin R, Lankes HA, Castellano T, Zamorano AS, Blank SV, Kachnic LA. Optimization of Timing for Risk-Reducing Salpingectomy and Oophorectomy. Obstet Gynecol. 2025 Jan 1;145(1):21-30. doi: 10.1097/AOG.0000000000005781. Epub 2024 Nov 7.
- Steenbeek MP, van Bommel MHD, intHout J, Peterson CB, Simons M, Roes KCB, Kets M, Norquist BM, Swisher EM, Hermens RPMG; TUBA-WISP II consortium; Lu KH, de Hullu JA. TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol. Int J Gynecol Cancer. 2023 Jun 5;33(6):982-987. doi: 10.1136/ijgc-2023-004377.
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Urogenitale sygdomme
- Genitale sygdomme
- Sygdomme i det endokrine system
- Urogenitale neoplasmer
- Neoplasmer efter sted
- Neoplasmer
- Urogenitale sygdomme hos kvinder
- Kvinders urogenitale sygdomme og graviditetskomplikationer
- Kønssygdomme, kvindelige
- Neoplasmer i endokrine kirtler
- Ovariesygdomme
- Adnexale sygdomme
- Genitale neoplasmer, kvindelige
- Gonadale lidelser
- Ovariale neoplasmer
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- NL 70691.091.19
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .